BIORETEC OY (0TN) - Total Assets
Based on the latest financial reports, BIORETEC OY (0TN) holds total assets worth €11.68 Million EUR (≈ $13.65 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BIORETEC OY - Total Assets Trend (2021–2025)
This chart illustrates how BIORETEC OY's total assets have evolved over time, based on quarterly financial data. Also see how much is BIORETEC OY worth for the company's overall valuation and market capitalisation.
BIORETEC OY - Asset Composition Analysis
Current Asset Composition (December 2025)
BIORETEC OY's total assets of €11.68 Million consist of 78.9% current assets and 21.1% non-current assets. Review how much debt does BIORETEC OY carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 35.3% |
| Accounts Receivable | €667.00K | 5.7% |
| Inventory | €3.89 Million | 33.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €992.36K | 8.5% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how BIORETEC OY's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 0TN stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIORETEC OY's current assets represent 78.9% of total assets in 2025, a decrease from 90.0% in 2021.
- Cash Position: Cash and equivalents constituted 35.3% of total assets in 2025, up from 1.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 2.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 33.3% of total assets.
BIORETEC OY Competitors by Total Assets
Key competitors of BIORETEC OY based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
BIORETEC OY - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.18 | 7.49 | 4.87 |
| Quick Ratio | 2.99 | 6.33 | 4.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €7.43 Million | €8.45 Million | €5.28 Million |
BIORETEC OY - Advanced Valuation Insights
This section examines the relationship between BIORETEC OY's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.65 |
| Latest Market Cap to Assets Ratio | 1.38 |
| Asset Growth Rate (YoY) | 1.8% |
| Total Assets | €11.68 Million |
| Market Capitalization | $16.10 Million USD |
Valuation Analysis
Above Book Valuation: The market values BIORETEC OY's assets above their book value (1.38x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: BIORETEC OY's assets grew by 1.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BIORETEC OY (2021–2025)
The table below shows the annual total assets of BIORETEC OY from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €11.68 Million ≈ $13.65 Million |
+1.78% |
| 2024-12-31 | €11.47 Million ≈ $13.42 Million |
+7.67% |
| 2023-12-31 | €10.66 Million ≈ $12.46 Million |
+205.58% |
| 2022-12-31 | €3.49 Million ≈ $4.08 Million |
-59.36% |
| 2021-12-31 | €8.58 Million ≈ $10.03 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more